ESPERITE N.V. convenes Extraordinary General Meeting of Shareholders to approve external financing

August 19, 2020 Group News

Esperite N.V. (Euronext: ESP, “Esperite” or the “Company”) announces that it has convened its Extraordinary General Meeting of Shareholders (“EGM”) to be held on 30 September 2020 at 14:00 CET at Hotel NH Amsterdam Barbizon Palace, Prins Hendrikkade 59-72, 1012 AD Amsterdam, the Netherlands.

 

The Netherlands – 19 August 2020

On 14 April 2020, the Company was placed in bankruptcy under the Dutch Bankruptcy Act. The Board of Directors intends to enter into negotiations with the current creditors of the Company and request their approval for the contemplated restructuring plan of the Company. The purpose of the EGM is amongst others to approve the external financing announced in the press release of 28 July 2020 in order to fund a restructuring plan and settlement with the Company’s creditors.

The EGM’s convocation notice, agenda and the explanatory notes to the agenda and further EGM materials can be downloaded from Esperite’s website (www.esperite.com) and are available free of charge at the registered office of Esperite (Vosselmanstraat 1, 7311 CL Apeldoorn).

Shareholders interested in attending the EGM are invited to contact Esperite: info@esperitegroup.com.

 

About Esperite

Esperite is a diversified investment company group. Established in 2000, Esperite is a holding company, listed at Euronext Amsterdam and Paris. Esperite invests in companies able to transform the power of state-of-the-art technologies and scientific advancements into high quality products. To learn more about Esperite, please contact info@esperitegroup.com or visit the websites at www.esperite.com.

***

PDF Downloads – EGM 30 September 2020

           Press Release : EGM-30-September-2020-Press-Release.pdf

          Agenda  :             EGM-30-September-2020-Agenda.pdf

          Notice  :               EGM-30-September-2020-Notice.pdf

Explanatory Notes : EGM-30-September-2020-Explanatory-Notes.pdf

Power of Attorney : EGM-30-September-2020-Power-of-Attorney.pdf

Minutes of AGM 9 January 2019   : Minutes-Esperite-AGM-9-January-2019.pdf

read more

Esperite NV announces a major change in its management and appoints its new CEO, Mr. Hugo Brugière.

August 5, 2020 Group News

5 August 2020

The Netherlands, August 5 2020 – The Board of Directors of Esperite N.V. (Euronext: ESP), at its meeting of 30 July, 2020, noted the departure of Frédéric Amar from his position as Chief Executive Officer for health reasons. Frédéric Amar maintains his mandate as Director and, as such, will continue to provide Esperite with the benefit of his expertise.

The Board, by unanimous vote of its members, decided to appoint Hugo Brugière as a director and to appoint him as Chief Executive Officer of Esperite. Hugo Brugière is notably Chairman of HBR Investment Group, a company specialising in the acquisition of stakes in distressed companies in need of managerial support in addition to a capital contribution. His most recent investment is Neovacs, a French biotechnology company listed on Euronext Growth in Paris.

Hugo Brugière is one of the investors in the European Small Caps Opportunities Fund, based in Australia (the “Fund”), from which Esperite secured a €35 million financing line on July 28, 2020. It is specified that (i) as a limited partner, Hugo Brugière has no decision-making power within the Fund and (ii) no privileged information that Hugo Brugière may hold in his capacity as Chief Executive Officer and director of Esperite may be transmitted to the Fund, in accordance with the terms of the contract concluded between Esperite and the Fund.

 

Frédéric Amar: “Esperite was a major project for me. I am pleased to hand over the management of the group to Hugo Brugière, whose energy and foresight make him the manager that Esperite needs for its development. The recent investment agreement that we signed should enable Esperite, under Hugo Brugière’s leadership, to envisage an ambitious development plan.

Hugo Brugière said: “After learning of the Fund’s investment in Esperite, I was seduced by the potential offered by this company. It was therefore natural for me to accept the directors’ offer to join the Board and become Chief Executive Officer. I will take the time to analyse the situation from the inside and then present my action plan. »

***

read more